C20H21F3N6O3S2 — CID 135352039
4-[(2R,4S)-2-(1H-pyrazol-5-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide (PubChem CID 135352039) has the molecular formula C20H21F3N6O3S2 and a molecular weight of 514.56 g/mol. Its IUPAC name is 4-[(2R,4S)-2-(1H-pyrazol-5-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide.
| Compound Name | 4-[(2R,4S)-2-(1H-pyrazol-5-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide |
|---|---|
| PubChem CID | 135352039 |
| Molecular Formula | C20H21F3N6O3S2 |
| Molecular Weight | 514.56 g/mol |
| Exact Mass | 514.11 |
| IUPAC Name | 4-[(2R,4S)-2-(1H-pyrazol-5-yl)-4-(trifluoromethyl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide |
| SMILES | O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCCC2N1CC[C@H](C(F)(F)F)C[C@@H]1c1ccn[nH]1 |
| InChI | InChI=1S/C20H21F3N6O3S2/c21-20(22,23)12-4-7-29(17(9-12)15-3-6-25-27-15)16-5-8-32-18-10-13(1-2-14(16)18)34(30,31)28-19-24-11-26-33-19/h1-3,6,10-12,16-17H,4-5,7-9H2,(H,25,27)(H,24,26,28)/t12-,16?,17+/m0/s1 |
| InChIKey | KXPNRUMXPOGTES-QMEQOSATSA-N |
| XLogP | 3.90 |
| TPSA | 113.10 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 514.56 |
| LogP ≤ 5 | 3.90 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |